Guest Blogger: RAAFT 2 Trial Summary May 19, 2012
Posted by Heart Rhythm Society in Atrial Fibrillation (AF), Science & Research, Scientific Sessions.Tags: Afib, Atrial fibrillation, RAAFT 2 Trial
add a comment
Editor’s Note: Guest blogger Aman Chugh, MD provides a summary of the RAAFT 2 trial results, which were presented at the Heart Rhythm Society’s 33rd Annual Scientific Sessions in Boston.
Catheter ablation of symptomatic paroxysmal atrial fibrillation (AF) is a class I indication in a patient who has not responded to or has not tolerated medical therapy with an antiarrhythmic medication. However, antiarrhythmic medications are limited by not only modest efficacy but also by significant adverse effects. (more…)
Guest Blogger: Live Case Sessions Review May 11, 2012
Posted by Heart Rhythm Society in Atrial Fibrillation (AF), Scientific Sessions.Tags: AF, Afib, Atrial fibrillation
add a comment
Editor’s Note: Guest blogger Kenneth Ellenbogen, MD, FHRS shares his thoughts on the live case session presented at the Heart Rhythm Society’s 33rd Annual Scientific Sessions.
Yesterday I attended the Live Cases Session at Heart Rhythm 2012 in Boston. The group at Brigham and Women’s Hospital, led by Dr. Gregory Michaud, performed catheter ablation of a patient with paroxysmal/persistent Atrial Fibrillation (AF). (more…)
Guest Blogger: ACC.12 Late-Breaking Clinical Trial Review, ISSUE 3 April 12, 2012
Posted by Heart Rhythm Society in Allied Health Professionals, EP Physicians, Science & Research.Tags: Clinical trial
add a comment
Editor’s Note: Guest blogger Kenneth Ellenbogen, MD, FHRS shares his thoughts on a late-breaking clinical trial presented at the American College of Cardiology’s 2012 Annual Scientific Sessions.
For the electrophysiology community, the biggest treat of the American College of Cardiology’s Annual Scientific Sessions was the Pacemaker Therapy in Patients with Neurally-mediated Syncope and Documented Asystole late-breaking clinical trial, presented by Dr. Michele Brignole on behalf of the ISSUE-3 investigators. (more…)
HRS Picks: Many Americans in the Dark about Heart Rhythm Disorders March 6, 2012
Posted by Heart Rhythm Society in Atrial Fibrillation (AF), Society News, Sudden Cardiac Arrest, Uncategorized.Tags: AF, Afib, Atrial fibrillation, SCA, Sudden Cardiac Arrest
add a comment
In the article below, published on the blog, Be Healthy, Well & Inspired, the Heart Rhythm Society’s omnibus survey results about Americans understanding of heart rhythm disorers are shared with readers. The Society also issued a press release about the results during Heart Health month. (more…)
Guest Blogger: Boston AF Symposium Highlights January 27, 2012
Posted by Heart Rhythm Society in Atrial Fibrillation (AF), Science & Research.Tags: AF, Afib, Atrial fibrillation, clinical guidelines
add a comment
Editor’s Note: Guest blogger Hugh Calkins, MD, FHRS, CCDS is the Heart Rhythm Scientific Sessions Program Committee Chair (2012). He provides a brief overview of the Boston AF Symposium, which took place January 12 – 14, 2012.
This year’s Boston AF Symposium was very well attended, with more than 1,200 participants. I would like to share a few highlights from the meeting: (more…)
Most Popular Posts of 2011 January 16, 2012
Posted by Heart Rhythm Society in Uncategorized.add a comment
EP Insights has had steady growth in readership and commentary since launching in February 2010. We would like to share the ten most popular posts of 2011 with you, encourage you to read any that you may have missed and contribute to the growing conversation among heart rhythm professionals.
- Education, Disclosures, and Bias, Oh My! (Part Two of Two) by Joshua Cooper, MD
In this post, Dr. Cooper is “evaluating the paradigm of Industry sponsorship of medical education.” - Appropriateness of ICD Use Challenged by Registry Study by Mark S. Kremers, MD, FHRS
Dr. Kremers discusses the findings of the study “Non–Evidence-Based ICD Implantations in the United States” noting that “the ICD Registry form should be reviewed by the physician to ensure accuracy and the supporting medical record should clarify issues that are not completely disclosed in the registry document. Increased attention to these issues will make the registry a better reflection of the care delivered and would be a positive development.” (more…)
Where will Data for Cardiac Electrophysiology Performance Measures be Derived? November 23, 2011
Posted by Heart Rhythm Society in Health Policy.Tags: Performance measures, Quality & Improvement
1 comment so far
Editor’s Note: The post below was written by EP Insights blogger, Bruce A. Koplan, MD, MPH, FHRS, of Brigham and Women’s Hospital Cardiac Arrhythmia Service.
There are limited measures of quality and performance that are unique to the field of cardiac electrophysiology. Currently, quality reporting is, for the most part, optional. Over the course of the next several years, however, physician reimbursement will increasingly be tied to performance. (more…)
Guest Blogger: Atrial Fibrillation and Stroke – Education for the Public September 28, 2011
Posted by Heart Rhythm Society in Atrial Fibrillation (AF), Education.Tags: AF, Afib, Atrial fibrillation, CHADS2 score, Stroke, Warfarin
2 comments
Editor’s Note: Guest blogger Aman Chugh, MD, is an assistant professor in the Division of Cardiology, University of Michigan. In his post, he aims to educate the public about atrial fibrillation and its relation to stroke.
Although atrial fibrillation (AF) is usually not a life threatening arrhythmia, it may still result in significant morbidity. It is a major cause of stroke, accounting for approximately 20% of all strokes. (more…)
Don’t miss the Society’s top Tweets September 13, 2011
Posted by Heart Rhythm Society in Society News.Tags: Twitter
add a comment
Be sure to visit the Heart Rhythm Society’s Twitter feed for the latest updates and items in the news. Below are last month’s top Tweets.
- Society update on coverage policies for Pacemakers, http://ow.ly/61CWs
- Dronedarone “dear doctor” letter sums up recent alerts, http://ow.ly/67L9A. See also @doctorwes post http://ow.ly/67LaM (more…)
HRS Update: FDA Issues Alert on the Heart Drug Multaq (dronedarone) July 22, 2011
Posted by Heart Rhythm Society in EP Physicians, Science & Research.Tags: AF, Afib, Atrial fibrillation, Clinical trials, Dronedarone, Multaq, PALLAS Study
add a comment
The U.S. Food and Drug Administration (FDA) is reviewing data from the Permanent Atrial Fibrillation Outcome Study Using Dronedarone on Top of Standard Therapy (PALLAS) study that was evaluating the effects of the antiarrhythmic drug Multaq (dronedarone) in patients with permanent atrial fibrillation. (more…)
Heart Rhythm Society
Laurie Racenet, RN, MSN, ANP
Michael Giudici, MD, FACC, FACP, FHRS
Heather M. Ross, DNP, ANP-BC, CCDS, CEPS, FHRS
Anne Dubin, MD, FHRS
John D. Day, MD, FHRS
Andrea M. Russo, MD, FACC, FHRS
Joshua M. Cooper, MD, FACC
Amit J. Shanker, MD, FHRS, FACC
Bruce Stambler, MD
David Wiggins, RN, BS BME, CEPS
Fred M. Kusumoto, MD, FHRS
Leonard Ganz, MD, FHRS
christinechiuman
Craig Delaughter, MD, PhD
Ariana Del Negro, Heart Rhythm 2010 Quality
Peng-Sheng Chen, MD, FHRS
MSKremers MD,FHRS
Ann C. Garlitski, MD, FACC, FHRS
Alan Cheng, MD, FHRS
Ulrika Birgersdotter-Green, MD
Christopher Clyne, MD, FHRS
Kathleen Blake, MD, MPH, FHRS
David Scher, MD, FHRS
Sanjay Deshpande, MD, FHRS
Thomas F. Deering, MD, FHRS
